Clinical Trials Browser

Terminated × INDUSTRY × sapacitabine × Clear all

NCT00476554 2021-12-22

A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma

Phase 2 Terminated

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT00885963 2021-12-22

A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung